Baseline characteristics clinical outcomes
| Variable (n = =154) | < 48 h (n = 49) (%) | > 48 h (n = 105) (%) |
|---|---|---|
| Female | 14 (28.6%) | 34 (32.3%) |
| Source of referral Primary Secondary Self | 15 (30.6%) 20 (40.8%) 14 (28.6%) | 70 (66.7%) 18 (17.1%) 17 (16.2%) |
| CHA2DS2-VASc score 0 1 2 3+ | 28 (57.1%) 7 (14.3%) 8 (16.3%) 6 (12.2%) | 19 (18.1%) 14 (13.3%) 22 (21.0%) 50 (47.6%) |
| HASBLED <1 >1 | 37 (75.5%) 12 (24.5%) | 37 (35.2%) 68 (64.8%) |
| Anticoagulation Already established Warfarin NOAC None | 11 (22.4%) 9 (81.8%) 2 (18.2%) 38 (77.6%) | 41 (39.0%) 40 (97.6%) 1 (2.4%) 64 (61.0%) |